PEAK6 Group’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-26,367
Closed -$1.05M 5359
2018
Q1
$819K Buy
26,367
+4,297
+19% +$141K ﹤0.01% 2135
2017
Q4
$660K Buy
22,070
+20,381
+1,207% +$590K ﹤0.01% 2253
2017
Q3
$56K Buy
+1,689
New +$58.5K ﹤0.01% 3980
2016
Q3
Sell
-15,759
Closed -$297K 5107
2016
Q2
$257K Buy
+15,759
New +$232K ﹤0.01% 2956
2014
Q3
Sell
-1,619
Closed -$12K 5687
2014
Q2
$12K Buy
+1,619
New +$12.9K ﹤0.01% 4410
2013
Q4
Sell
-48,208
Closed -$239K 6028
2013
Q3
$239K Buy
48,208
+21,058
+78% +$166K ﹤0.01% 3530
2013
Q2
$160 Buy
+27,150
New +$91.4K ﹤0.01% 3810

Other funds holding BEAT

PEAK6 Group's BEAT Position: Q2 2018 in Review

PEAK6 Group sold out of BioTelemetry, Inc. (BEAT) in Q2 2018, closing a stake of 26,367 shares — an estimated $1.05M sold.

PEAK6 Group first reported a position in BEAT in Q2 2013 and held it in 7 quarters. The position peaked at $819K in Q1 2018. 227 funds tracked by Wall St. Rank hold BEAT as of Q2 2018.

  • PEAK6 Group reported no remaining BioTelemetry, Inc. position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 26,367 BioTelemetry, Inc. shares in Q2 2018, an estimated $1.05M.
  • PEAK6 Group first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 7 quarters.
  • PEAK6 Group's BioTelemetry, Inc. position peaked at $819K in Q1 2018.
  • 227 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.